Dorzolamide Hydrochloride

Specifications

130693-82-2CAS Number

620-304-2EC Number

(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochlorideIUPAC Name

C10H17ClN2O4S3Chemical Formula

360.9 g/molMolecular Weight

DORZOLAMIDE HYDROCHLORIDE; 130693-82-2; Dorzolamide HCl; DTXSID1045530; Dorzolamide (as hydrochloride); QZO5366EW7; DTXCID9025530; CHEBI:4703; Dorzolamide PF; Dorzolamide HCI; RefChem:57215; Dorzolamide Hydrochloride Ophthalmic; (4S,6S)-4-Ethylamino-6-methyl-5,6-dihydro-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide monohydrochloride; Dorzolomide hydrochloride; Trusopt; Cosopt; (4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride; Dorzolamide (hydrochloride); rac-trans Dorzolamide hydrochloride; MK-507; MFCD00884659; Trusopt (TN); (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride; 120279-36-9; C10H17ClN2O4S3; (4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride; 4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, monohydrochloride, (4S-trans)-; UNII-QZO5366EW7; SR-05000001449; Dorzolamide hydrochloride [USAN]; (4R,6R)-rel-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-Dioxide Monohydrochloride; trans-4-(Ethylamino)-5,6-dihydro-6- methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-Dioxide Monohydrochloride;; (4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride; L671152;MK507; Dorzolamide hydrochloride [USAN:USP]; L671152 hydrochloride;MK507 hydrochloride; MK 0507; MK-0507; NCGC00016977-01; CAS-130693-82-2; SCHEMBL41152; Dorzolamide hydrochloride CRS; (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride; MLS002154162; L 671152; HY-B0109AR; L-671,152; orb1306395; CHEMBL1201162; HY-B0109A; GLXC-05062; HMS1571O14; EX-A3987; Tox21_110720; Dorzolamide HCl - Bio-X trade mark; EBC-79037; s1375; DORZOLAMIDE HYDROCHLORIDE [MI]; AKOS005146235; AKOS015895951; Dorzolamide for system suitability CRS; Dorzolamide hydrochloride (JP18/USP); Tox21_110720_1; AC-5244; CCG-221116; CS-1858; Dorzolamide (hydrochloride) (Standard); DORZOLAMIDE HYDROCHLORIDE [JAN]; FD41116; KS-1348; Dorzolamide hydrochloride [EP monograph]; DORZOLAMIDE HYDROCHLORIDE [MART.]; DORZOLAMIDE HYDROCHLORIDE [VANDF]; NCGC00179244-03; BD164381; DORZOLAMIDE HYDROCHLORIDE [USP-RS]; DORZOLAMIDE HYDROCHLORIDE [WHO-DD]; SMR001233461; D4189; T2134; DORZOLAMIDE HYDROCHLORIDE, TRANS-(-)-; C72221; D00653; DORZOLAMIDE HYDROCHLORIDE [ORANGE BOOK]; DORZOLAMIDE HYDROCHLORIDE [USP IMPURITY]; COSOPT COMPONENT DORZOLAMIDE HYDROCHLORIDE; DORZOLAMIDE HYDROCHLORIDE [USP MONOGRAPH]; EN300-19768601; F868829; L-671152; SR-05000001449-3; Q27106441; Z2756516872; Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard; Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard; Dorzolamide hydrochloride, United States Pharmacopeia (USP) Reference Standard; (2S,4S)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1lambda6-thieno[2,3-b]thiopyran-6-sulfonamide hydrochloride; (4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide 4H-Thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride; (4S,6S)-4-(Ethylamino)-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda~6~-thieno[2,3-b]thiopyran-2-sulfonamide--hydrogen chloride (1/1); 4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-4-(ethylamino)-6-methyl-, 7,7-dioxide, monohydrochloride, (4S,6S)-Synonyms